Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-24-014552
Filing Date
2024-11-06
Accepted
2024-11-06 11:11:00
Documents
16
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 6-K gmab-20241106x6k.htm 6-K 22472
2 EX-99.1 gmab-20241106xex99d1.htm EX-99.1 1476951
3 GRAPHIC gmab-20241106xex99d1002.jpg GRAPHIC 4880
4 GRAPHIC gmab-20241106xex99d1005.jpg GRAPHIC 105809
5 GRAPHIC gmab-20241106xex99d1006.jpg GRAPHIC 82229
6 GRAPHIC gmab-20241106xex99d1007.jpg GRAPHIC 2487
7 GRAPHIC gmab-20241106xex99d1008.jpg GRAPHIC 4045
8 GRAPHIC gmab-20241106xex99d1009.jpg GRAPHIC 1611
9 GRAPHIC gmab-20241106xex99d1010.jpg GRAPHIC 2062
10 GRAPHIC gmab-20241106xex99d1011.jpg GRAPHIC 2922
11 GRAPHIC gmab-20241106xex99d1012.jpg GRAPHIC 2301
12 GRAPHIC gmab-20241106xex99d1013.jpg GRAPHIC 2771
13 GRAPHIC gmab-20241106xex99d1014.jpg GRAPHIC 3564
14 GRAPHIC gmab-20241106xex99d1015.jpg GRAPHIC 2238
15 GRAPHIC gmab-20241106xex99d1016.jpg GRAPHIC 3370
16 GRAPHIC gmab-20241106xex99d1017.jpg GRAPHIC 1434
  Complete submission text file 0001558370-24-014552.txt   1807995
Mailing Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
Business Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
GENMAB A/S (Filer) CIK: 0001434265 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38976 | Film No.: 241429690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)